Literature DB >> 19026760

Peptides from Paracoccidioides brasiliensis GP43 inhibit macrophage functions and inflammatory response.

Adriana Y C Konno1, Juliana T Maricato, Fabiana T C Konno, Mário Mariano, José Daniel Lopes.   

Abstract

Paracoccidioidomycosis (PCM) is a systemic granulomatous disease caused by Paracoccidioides brasiliensis (Pb), a thermal dimorphic fungus. Its major antigen is a 43-kDa glycoprotein. Gp43 embodies different functions: it participates in evasion mechanisms during the installation of primary infection, stimulates granuloma-like formation in vitro and presents T-cell epitopes that induce protective response against the fungus. Here, we investigated epitopes from gp43 inhibitory of both, macrophage functions and inflammatory reaction. Different gp43 peptides, spanning the entire sequence of the molecule, were added to cultures of bone marrow-derived macrophages. After challenge with zymosan or Pb cells, phagocytic indexes were measured. Peptides expressed on the molecule surface were determined by graphic analysis using the Protean module; DNAstar Inc. Two peptides which decreased phagocytic index and were expressed at the surface of the molecule, P4 and P23, were selected for further studies. It was shown that both inhibited the release of NO by zymosan stimulated macrophages while enhanced release of H(2)O(2). The release of TNF-alpha in culture supernatants from in vitro phagocytic tests showed different response depending of P4 concentration (data not shown). In vivo assays with Mycobacterium bovis - bacillus Calmette-Guérin (BCG) or Pb cells demonstrated that these peptides presented non-specific and specific anti-inflammatory properties.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026760     DOI: 10.1016/j.micinf.2008.10.011

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  6 in total

Review 1.  PARACOCCIDIOIDOMYCOSIS: CHALLENGES IN THE DEVELOPMENT OF A VACCINE AGAINST AN ENDEMIC MYCOSIS IN THE AMERICAS.

Authors:  Carlos P Taborda; M E Urán; J D Nosanchuk; L R Travassos
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-09       Impact factor: 1.846

2.  Anti-inflammatory and immunomodulatory effect of an extract of Coccidioides posadasii in experimental arthritis.

Authors:  Ana Carolina Matias Dinelly Pinto; Rossana de Aguiar Cordeiro; José Julio Costa Sidrim; Ana Karine Rocha de Melo Leite; Ana Caroline Rocha de Melo Leite; Virgínia Cláudia Carneiro Girão; Raimunda Sâmia Nogueira Brilhante; Marcos Fábio Gadelha Rocha; Fernando de Queiroz Cunha; Francisco Airton Castro Rocha
Journal:  Mycopathologia       Date:  2013-02-05       Impact factor: 2.574

3.  Analysis of the secretomes of Paracoccidioides mycelia and yeast cells.

Authors:  Simone Schneider Weber; Ana Flávia Alves Parente; Clayton Luiz Borges; Juliana Alves Parente; Alexandre Melo Bailão; Célia Maria de Almeida Soares
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

4.  Identification and Analysis of the Role of Superoxide Dismutases Isoforms in the Pathogenesis of Paracoccidioides spp.

Authors:  Diana Tamayo; José F Muñoz; Ángela Lopez; Martha Urán; Juan Herrera; Clayton L Borges; Ángela Restrepo; Celia M Soares; Carlos P Taborda; Agostinho J Almeida; Juan G McEwen; Orville Hernández
Journal:  PLoS Negl Trop Dis       Date:  2016-03-10

Review 5.  Anti-Immune Strategies of Pathogenic Fungi.

Authors:  Caroline M Marcos; Haroldo C de Oliveira; Wanessa de Cássia M Antunes de Melo; Julhiany de Fátima da Silva; Patrícia A Assato; Liliana Scorzoni; Suélen A Rossi; Ana C A de Paula E Silva; Maria J S Mendes-Giannini; Ana M Fusco-Almeida
Journal:  Front Cell Infect Microbiol       Date:  2016-11-15       Impact factor: 5.293

6.  Inhibition of PbGP43 expression may suggest that gp43 is a virulence factor in Paracoccidioides brasiliensis.

Authors:  Isaura Torres; Orville Hernandez; Diana Tamayo; Jose F Muñoz; Natanael P Leitão; Ana M García; Angela Restrepo; Rosana Puccia; Juan G McEwen
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.